
DCP · Dis-Chem Pharmacies Limited
22.94
ZARUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
R20.55B
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Payout Ratio
40%
MQV Rating
5Very Weak
As at 17/11/2026 12:00:00 AM
Price StockChart
Description
- All-Companies
- All-Consensus
- HALO 100
- HALO 200
- HALO All
- HALO Dividend Growth
Key Fundamentals
EPS 3 yr Growth
1.70%
EBITDA Margin
7.30%
Operating Cashflow
R2,317m
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
5.60
Quick Ratio
N/A
Performance
52 weeks range
Low 23.25 - 39
Trade Value (12mth)
US$568,538.00
1 week
-1.44%
1 month
-12.2%
YTD
-32.46%
1 year
-32.55%
All time high
40.00
Additional Data
Shares Outstanding (Fully Diluted)
857m
HALO Sector
Healthcare
Next Company Report Date
28-May-27
Next Ex Dividend Date
18-Nov-26
Next Dividend Pay Date
23-Nov-26
Reporting Currency
ZAR
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Very Weak
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Very Weak
Growth
Earnings
Neutral
Dividends
Very Strong
Quality
Capital Efficiency
Strong
Balance Sheet
Very Weak
Valuation
News & Announcements
No announcements available.
Key Stakeholders
| Name | Title |
| Saltzman Family | Individual |
| Royal Bafokeng Holdings (Pty) Ltd. | Subsidiary |
| Stansh Pty Ltd. | Private Company |